You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression
- 2. Scientists create a type of catalog, the 'colocatome,' of non-cancerous cells' influence on cancer
- 3. Walking, moving more may lower risk of cardiovascular death for women with cancer history
- 4. Revolutionising cancer treatment: targeting EZH2 for a new era of precision medicine
- 5. Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients
- 6. Integrating quantitative DCE-MRI parameters and radiomic features for improved IDH mutation prediction in gliomas
- 7. Efficacy of thunder-fire moxibustion for cancer-related fatigue in breast cancer survivors: study protocol for a randomized controlled trial
- 8. EZH2: An analysis of a potential new tumor marker in high-risk localization of cutaneous squamous cell carcinomas
- 9. New avenues in breast cancer treatment: The role of ubiquitin-specific proteases in programmed cell death
- 10. Pfizer and Arvinas's HER2-breast cancer drug extends PFS in certain patients
Last updated at 21:32 GMT
Hot News Makers
Health/Pharma Companies
-
285048.91
-
77397.59
-
24558.71
-
17515.79
-
11482.78
-
7085.34
-
7070.79
-
6305.95
-
5871.58
-
5304.67
Drugs, Treatments, Trials
-
8011.05
-
6158.31
-
6031.63
-
4523.72
-
4365.17
-
4300.18
-
4189.34
-
4030.21
-
3793.14
-
3105.21
Last updated at 21:10 GMT
